Recent Advances in Anticancer Research of Osmium and Rhodium Complexes

Area of Science:

• Medicinal Chemistry
• Inorganic Chemistry
• Oncology

Background:

• Platinum and ruthenium complexes are established metal-based anticancer agents but face challenges with toxicity and drug resistance.
• There is a growing need for novel metal antitumor complexes with improved efficacy and safety profiles.
• Osmium and rhodium complexes are emerging as promising candidates in cancer chemotherapy.

Purpose of the Study:

• To review recent developments in osmium and rhodium complexes as novel chemotherapeutic agents.
• To highlight their potential as alternatives to conventional platinum and ruthenium anticancer drugs.
• To underscore the need for further investigation into their biological effects and mechanisms of action.

Main Methods:

• Literature review of recent studies on osmium and rhodium-based anticancer complexes.
• Analysis of reported antitumor activity, toxicity profiles, and mechanisms of action.
• Comparison with established platinum and ruthenium anticancer compounds.

Main Results:

• Osmium and rhodium complexes demonstrate significant antitumor activity, often equipotent to platinum and ruthenium analogues.
• Many developed Os and Rh complexes exhibit lower toxic effects compared to conventional agents.
• These complexes display diverse modes of action, differing from traditional platinum and ruthenium compounds.

Conclusions:

• Osmium and rhodium complexes represent a promising class of novel chemotherapeutic agents.
• Their distinct mechanisms and favorable toxicity profiles warrant further investigation as potential cancer treatments.
• Continued research into these metal-based compounds could lead to new therapeutic strategies against cancer.